These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 26696400

  • 1. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
    Saida T, Tanaka YO, Matsumoto K, Satoh T, Yoshikawa H, Minami M.
    Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
    [Abstract] [Full Text] [Related]

  • 2. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I, Minář L, Felsinger M, Anton M, Bednaříková M, Hausnerová J, Jandáková E, Weinberger V.
    Ceska Gynekol; 2017 Feb; 82(3):230-236. PubMed ID: 28593778
    [Abstract] [Full Text] [Related]

  • 3. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
    Katabathina VS, Amanullah FS, Menias CO, Chen MM, Valente PT, Chintapalli KN, Prasad SR.
    Radiographics; 2016 Feb; 36(3):918-32. PubMed ID: 27163599
    [Abstract] [Full Text] [Related]

  • 4. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R.
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [Abstract] [Full Text] [Related]

  • 5. Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
    Ohsuga T, Yamaguchi K, Kido A, Murakami R, Abiko K, Hamanishi J, Kondoh E, Baba T, Konishi I, Matsumura N.
    BMC Cancer; 2017 Aug 29; 17(1):580. PubMed ID: 28851311
    [Abstract] [Full Text] [Related]

  • 6. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer.
    Seidman JD, Zhao P, Yemelyanova A.
    Gynecol Oncol; 2011 Mar 29; 120(3):470-3. PubMed ID: 21159368
    [Abstract] [Full Text] [Related]

  • 7. Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.
    Singh N, Gilks CB, Wilkinson N, McCluggage WG.
    Histopathology; 2014 Aug 29; 65(2):149-54. PubMed ID: 24660659
    [Abstract] [Full Text] [Related]

  • 8. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases.
    Tang S, Onuma K, Deb P, Wang E, Lytwyn A, Sur M, Daya D.
    Int J Gynecol Pathol; 2012 Mar 29; 31(2):103-10. PubMed ID: 22317864
    [Abstract] [Full Text] [Related]

  • 9. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
    Höhn AK, Klagges S, Gläser A, Taubenheim S, Dornhöfer N, Einenkel J, Hiller GGR, Brambs CE, Horn LC.
    J Cancer Res Clin Oncol; 2021 Mar 29; 147(3):911-925. PubMed ID: 32915262
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging findings of extrauterine high-grade serous carcinoma based on new pathologic criteria for primary site assignment.
    Kawaguchi M, Kato H, Hatano Y, Tomita H, Hara A, Miyazaki T, Matsuo M.
    Acta Radiol; 2021 May 29; 62(5):687-694. PubMed ID: 32576024
    [Abstract] [Full Text] [Related]

  • 11. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T, Pestereli E, Erol O, Bozkurt S, Erdogan G, Simsek T.
    Int J Gynecol Cancer; 2016 Jul 29; 26(6):1012-9. PubMed ID: 27206284
    [Abstract] [Full Text] [Related]

  • 12. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y, Chen XD, Lü BJ, Zhou CY, Zhang XF, Shi HY.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct 29; 46(10):724-8. PubMed ID: 22321343
    [Abstract] [Full Text] [Related]

  • 13. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer).
    Seidman JD.
    Int J Gynecol Pathol; 2015 Mar 29; 34(2):112-20. PubMed ID: 25675178
    [Abstract] [Full Text] [Related]

  • 14. Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.
    Singh N, Gilks CB, Wilkinson N, McCluggage WG.
    Histopathology; 2015 Sep 29; 67(3):331-7. PubMed ID: 25640750
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?
    Gao FF, Bhargava R, Yang H, Li Z, Zhao C.
    Hum Pathol; 2013 Aug 29; 44(8):1534-43. PubMed ID: 23465279
    [Abstract] [Full Text] [Related]

  • 16. Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO).
    Prat J, FIGO Committee on Gynecologic Oncology.
    Obstet Gynecol; 2015 Jul 29; 126(1):171-4. PubMed ID: 26241270
    [No Abstract] [Full Text] [Related]

  • 17. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
    Mahe E, Tang S, Deb P, Sur M, Lytwyn A, Daya D.
    Int J Gynecol Pathol; 2013 Jul 29; 32(4):353-7. PubMed ID: 23722507
    [Abstract] [Full Text] [Related]

  • 18. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
    Chêne G, Dauplat J, Radosevic-Robin N, Cayre A, Penault-Llorca F.
    Bull Cancer; 2013 Jul 29; 100(7-8):757-64. PubMed ID: 23831931
    [Abstract] [Full Text] [Related]

  • 19. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC.
    Int J Gynecol Pathol; 2011 Sep 29; 30(5):417-24. PubMed ID: 21804388
    [Abstract] [Full Text] [Related]

  • 20. The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
    Toptas T, Pestereli E, Simsek T, Bozkurt S, Erdogan G, Karaveli S.
    J Cancer Res Ther; 2018 Sep 29; 14(3):587-592. PubMed ID: 29893323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.